文献速递生殖医学妇科

人类女性不孕症与性发育差异中单基因-疾病关系的系统综述与证据评估

A systematic review and evidence assessment of monogenic gene-disease relationships in human female infertility and differences in sex development.
PubMed 文献 · Hum Reprod Update · 2023-01-01

该研究遵循PRISMA指南系统检索1988年1月1日至2021年11月1日PubMed与Web of Science文献,筛选1078篇提取基因与变异,鉴定395个基因、验证466个基因-疾病关系,并绘制含105个基因的遗传诊断流程图,但未纳入遗传风险因素及寡基因/多基因病因。

要点

  • 共鉴定395个基因、验证466个基因-疾病关系,覆盖女性不孕症与性发育差异的单基因病因。
  • 提出包含105个至少有中等证据基因的遗传诊断流程图,并给出未来研究建议。
  • 研究未考虑相关遗传风险因素或女性不孕症的寡基因/多基因病因。

核心结论

  • 系统综述现有女性不孕症与性发育差异遗传学研究,可支持使用已验证基因开发诊断面板。
  • 全基因组分析正从以研究为主转向临床应用,将减少特发性病例并提升遗传咨询效果。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索PubMed与Web of Science 1988年1月1日至2021年11月1日文献。
  • 共识别45271篇出版物进行筛选,其中1078篇被选用于基因和变异提取。
  • 采用标准化评分系统评估表型由特定基因致病变异所致的证据,对每个基因-疾病关系赋予最终评分(无证据、有限、中等、强或确定性)。

主要发现

  • 共鉴定395个基因并验证466个基因-疾病关系,覆盖所有已报道的女性不孕症与性发育差异单基因病因。
  • 提出包含105个至少有中等证据基因的遗传诊断流程图,并给出未来研究建议。

关键数值与推荐

  • 每个基因-疾病关系的证据按标准化评分系统评为无证据、有限、中等、强或确定性。
  • 遗传诊断流程图纳入105个至少有中等证据的基因。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 研究未考虑相关遗传风险因素或女性不孕症的寡基因/多基因病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As in other domains of medicine, high-throughput sequencing methods have led to the identification of an ever-increasing number of gene variants in the fields of both male and female infertility. The increasing number of recently identified genes allows an accurate diagnosis for previously idiopathic cases of female infertility and more appropriate patient care. However, robust evidence of the gene-disease relationships (GDR) allowing the proper translation to clinical application is still missing in many cases. OBJECTIVE AND RATIONALE: An evidence-based curation of currently identified genes involved in female infertility and differences in sex development (DSD) would significantly improve both diagnostic performance and genetic research. We therefore performed a systematic review to summarize current knowledge and assess the available GDR. SEARCH METHODS: PRISMA guidelines were applied to curate all available information from PubMed and Web of Science on genetics of human female infertility and DSD leading to infertility, from 1 January 1988 to 1 November 2021. The reviewed pathologies include non-syndromic as well as syndromic female infertility, and endocrine and reproductive system disorders. The evidence that an identified phenotype is caused by pathogenic variants in a specific gene was assessed according to a standardized scoring system. A final score (no evidence, limited, moderate, strong, or definitive) was assigned to every GDR. OUTCOMES: A total of 45 271 publications were identified and screened for inclusion of which 1078 were selected for gene and variant extraction. We have identified 395 genes and validated 466 GDRs covering all reported monogenic causes of female infertility and DSD. Furthermore, we present a genetic diagnostic flowchart including 105 genes with at least moderate evidence for female infertility and suggest recommendations for future research. The study did not take into account associated genetic risk factor(s) or oligogenic/polygenic causes of female infertility. WIDER IMPLICATIONS: We have comprehensively reviewed the existing research on the genetics of female infertility and DSD, which will enable the development of diagnostic panels using validated genes. Whole genome analysis is shifting from predominantly research to clinical application, increasing its diagnostic potential. These new diagnostic possibilities will not only decrease the number of idiopathic cases but will also render genetic counselling more effective for infertile patients and their families.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Van Der Kelen A, Okutman Ö, Javey E, et al. A systematic review and evidence assessment of monogenic gene-disease relationships in human female infertility and differences in sex development. Hum Reprod Update. 2023. PMID: 36571510. doi:10.1093/humupd/dmac044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。